Literature DB >> 26352876

Genetics of Congenital Corneal Opacification--Impact on Diagnosis and Treatment.

Ken K Nischal1.   

Abstract

As our understanding of phenotype has improved with improving anterior segment imaging, it has become increasingly clear that the early genotype-phenotype correlations were largely misled by inaccurate phenotyping. Using a novel classification, congenital or neonatal corneal opacification can be considered to be primary or secondary. Secondary corneal disease may be developmental or acquired. Genetic analysis using this phenotypic classification becomes easier to navigate. Primary corneal disease includes endothelial dystrophies, corneal dermoids, cornea plana, and CYP1B1 cytopathy. Genotyping for all these conditions is reasonably advanced. Secondary developmental corneal disease includes entities that are the least well understood genotypically. These are kerato-irido-lenticular dysgenesis (also known as Peters anomaly, types 1 and 2). The genotyping literature of these conditions is littered with confusion. Iridocorneal adhesions (Peters anomaly 1) are often avascular, whereas keratolenticular adhesions (Peters anomaly 2) are usually vascularized. Children with a known molecular diagnosis can have iridocorneal adhesion in one eye and keratolenticular adhesion in the other eye. This further supports the notion that Peters anomaly 1 or 2 is a sign and not a diagnosis. Further types of kerato-irido-lenticular dysgenesis are those in which the lens fails to form or forms and then degenerates. Genotyping in these cases has been somewhat more fruitful but, as always, not comprehensive. If the lens fails to form or forms partially, the gene involved is FOXE3, which is a lens gene. Not surprisingly, if the lens forms partially or fails to form, this has an effect on the vitreous and the drainage angle. These cases are often associated with severe glaucoma. Other secondary developmental corneal diseases may include Axenfeld-Rieger syndrome, Aniridia, and primary congenital glaucoma, all of which have specific genotypic characterization. Other secondary causes are acquired and include infection, trauma, and metabolic disorders.

Entities:  

Mesh:

Year:  2015        PMID: 26352876     DOI: 10.1097/ICO.0000000000000552

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  [Combined XEN and Baerveldt implant-principles and management of complications].

Authors:  E Gerstenberger; E M Hoffmann; V Prokosch-Willing; F Grehn
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

2.  De Novo Missense Variants in WDR37 Cause a Severe Multisystemic Syndrome.

Authors:  Linda M Reis; Elena A Sorokina; Samuel Thompson; Sanaa Muheisen; Milen Velinov; Carlos Zamora; Arthur S Aylsworth; Elena V Semina
Journal:  Am J Hum Genet       Date:  2019-07-18       Impact factor: 11.025

3.  Clinicopathologic Features and Treatment Characteristics of Congenital Corneal Opacity Infants and Children Aged 3 Years or Less: A Retrospective Single Institution Analysis.

Authors:  Sen Miao; Qi Lin; Yang Liu; Yao-Wen Song; Ying-Nan Zhang; Zhi-Qiang Pan
Journal:  Med Princ Pract       Date:  2019-06-28       Impact factor: 1.927

Review 4.  [Diagnostics, clinical aspects and genetics of congenital corneal opacities].

Authors:  M Matthaei; S Zwingelberg; S Siebelmann; A Howaldt; M Mestanoglu; S L Schlereth; C Giezelt; J Dötsch; J Fricke; A Neugebauer; A Lappas; T Dietlein; S Roters; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2022-03-04       Impact factor: 1.059

5.  The clinical outcomes of keratoplasty in irreversible corneal decompensation secondary to Axenfeld-Rieger syndrome.

Authors:  Ting Yu; Jing Hong; Ge-Ge Xiao; Rong-Mei Peng
Journal:  Int Ophthalmol       Date:  2022-05-20       Impact factor: 2.029

6.  A zebrafish model of foxe3 deficiency demonstrates lens and eye defects with dysregulation of key genes involved in cataract formation in humans.

Authors:  M Krall; S Htun; D Anand; D Hart; S A Lachke; A M Slavotinek
Journal:  Hum Genet       Date:  2018-04-30       Impact factor: 4.132

7.  [Infant with bilateral corneal opacity and aniridia].

Authors:  Helena Wagner; Uta Matysiak; Wolf A Lagrèze
Journal:  Ophthalmologe       Date:  2020-11       Impact factor: 1.059

8.  Transcriptome from opaque cornea of Fanconi anemia patient uncovers fibrosis and two connected players.

Authors:  Bharesh K Chauhan; Anagha Medsinge; Hannah L Scanga; Charleen T Chu; Ken K Nischal
Journal:  Mol Genet Metab Rep       Date:  2021-01-27

Review 9.  The genetic architecture of aniridia and Gillespie syndrome.

Authors:  Hildegard Nikki Hall; Kathleen A Williamson; David R FitzPatrick
Journal:  Hum Genet       Date:  2018-09-22       Impact factor: 4.132

10.  Optical Coherence Tomography-Guided Transepithelial Phototherapeutic Keratectomy for Central Corneal Opacity in the Pediatric Population.

Authors:  Sloan W Rush; Ryan B Rush
Journal:  J Ophthalmol       Date:  2018-12-24       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.